| Primary |
| Arrhythmia Supraventricular |
25.0% |
| Heart Rate Irregular |
25.0% |
| Oral Candidiasis |
25.0% |
| Ventricular Tachycardia |
25.0% |
|
| Autoimmune Thrombocytopenia |
20.0% |
| Electrocardiogram Qrs Complex Prolonged |
20.0% |
| Incoherent |
20.0% |
| Medication Error |
20.0% |
| Renal Impairment |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
50.0% |
| Epilepsy |
16.7% |
| Atrial Fibrillation |
8.3% |
| Depression |
8.3% |
| Muscle Spasms |
8.3% |
| Pain |
8.3% |
|
| Neutropenic Sepsis |
20.0% |
| Pain |
20.0% |
| Sudden Cardiac Death |
20.0% |
| Suicidal Ideation |
20.0% |
| Vital Functions Abnormal |
20.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.6% |
| Drug Use For Unknown Indication |
12.8% |
| Hypertension |
11.0% |
| Blood Pressure |
5.3% |
| Imaging Procedure |
4.3% |
| Atrial Fibrillation |
3.9% |
| Cardiac Disorder |
3.9% |
| Myasthenic Syndrome |
3.2% |
| Neoplasm Malignant |
3.2% |
| Heart Rate Irregular |
2.8% |
| Multiple Sclerosis |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Affect Lability |
2.1% |
| Depression |
2.1% |
| Hypertensive Heart Disease |
1.8% |
| Hypothyroidism |
1.8% |
| Nuclear Magnetic Resonance Imaging Brain |
1.8% |
| Anticoagulant Therapy |
1.4% |
| Atrial Flutter |
1.4% |
| Malaria |
1.4% |
|
| Weight Decreased |
17.1% |
| Vomiting |
11.8% |
| Unevaluable Event |
10.5% |
| Respiratory Disorder |
6.6% |
| Skin Tightness |
6.6% |
| Self Injurious Behaviour |
5.3% |
| Alcohol Abuse |
3.9% |
| Pain In Extremity |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Waist Circumference Increased |
3.9% |
| Back Pain |
2.6% |
| Drug Ineffective |
2.6% |
| Dyspnoea |
2.6% |
| Hypersensitivity |
2.6% |
| Hypertension |
2.6% |
| International Normalised Ratio Decreased |
2.6% |
| Oedema Peripheral |
2.6% |
| Treatment Noncompliance |
2.6% |
| Troponin Increased |
2.6% |
| Upper Respiratory Tract Infection |
2.6% |
|
